Wednesday, January 25, 2012

Roche Buys Illumina For $5.7B Huge Consequences For Personalized Medicine

Roche is the world's largest maker of cancer drugs acquires gene sequencing company Illumina for $5.7B.

Roche is already the world's largest maker of cancer drugs, where gene analysis is progressing fastest, as well as a major maker of diagnostic tests.

Several cancer drugs are coming off patent AND gene therapy threatens this industry.

What would be the best (and cheapest) way to continue to generate revenue from your drug that is now off patent?....hint, by licensing the patented method for delivering the generic version.  (this method was called the biggest breakthrough invention for treating cancer)

(read how it works)

Look for a smart company to buy GENE, use their non-coding (junk DNA) patents (as well as Perlegen IP) to generate cash flow while they look to get paid every time a cancer drug is administered.(they own 70% of this cancer breakthrough technology)

There's a reason many are calling this the "next investing boom"

Here is an excerpt from the book How To Find Big Stocks It discusses the companies and technologies to look for in this upcoming wave.

I consider this wave the biggest “problem solver” ever that will affect every person in the world, rich or poor. It will create and destroy multi-billion dollar companies.

The 30,000 "switches" in your body (genes) or the "software of life", represent the next investing boom.

With the Internet boom, the first movers were the chip companies, PC manufacturers, and Internet providers. They provided the infrastructure to make it happen. It was people selling maps, picks and shovels that made the fortunes during the gold rush boom.

With the personalized medicine boom, the first movers will be (and already are) the companies that: provide access to the human genome (DNA), the testing kit manufacturers, DNA analysis technology, and the testing companies themselves.

The amount of money that will be spent by various industries and people, to live longer and better will be in the trillions.

The tool that turned $10,000 into $2,800,000 in 2 years.

No comments: